跳至主要内容
临床试验/ISRCTN92106665
ISRCTN92106665已完成未知

Effectiveness of ORAl hydroxocobalamin in treatment of vitamin B12 deficiency with neurological manifestations: a single-centre, prospective, open-label study

Hassan II Hospital (Morroco)0 个研究点目标入组 40 人开始时间: 2011年9月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

  1. 2016 results in https://www.ncbi.nlm.nih.gov/pubmed/27416488 (added 21/01/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Presence of neurological signs due to vitamin B12 deficiency, unexplained by other causes, with a rate of serum vitamin B12 <200 pg / ml

排除标准

  • 1. Patients previously treated for vitamin B12 deficiency
  • 2. Patients aged under 18 or over 80 years
  • 3. Patients with vitamin B12 deficiency corrected without resorting to the long-term supplementation

研究者

发起方
Hassan II Hospital (Morroco)

相似试验